Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 10, 2017 - Issue 8
Submit an article Journal homepage
556
Views
4
CrossRef citations to date
0
Altmetric
Drug Profile

AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine

Stephen SilbersteinDepartment of Neurology, Jefferson Headache Center, Philadelphia, PA, USACorrespondence[email protected]
View further author information
Pages 821-832 | Received 15 Aug 2016, Accepted 05 Jun 2017, Published online: 03 Jul 2017

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stephen D. Silberstein. (2018) A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine. Expert Opinion on Drug Safety 17:1, pages 89-97.
Read now

Articles from other publishers (3)

Yuxing Liu & Dawei Wu. (2023) Bi‐directional nasal drug delivery systems: A scoping review of nasal particle deposition patterns and clinical application. Laryngoscope Investigative Otolaryngology.
Crossref
Guanglu Li, Shaojie Duan, Tiantian Zhu, Zhiying Ren, Hui Xia, Ziyao Wang, Lei Liu & Zunjing Liu. (2023) Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis. The Journal of Headache and Pain 24:1.
Crossref
Laura Tiozzo Fasiolo, Michele Dario Manniello, Elena Tratta, Francesca Buttini, Alessandra Rossi, Fabio Sonvico, Fabrizio Bortolotti, Paola Russo & Gaia Colombo. (2018) Opportunity and challenges of nasal powders: Drug formulation and delivery. European Journal of Pharmaceutical Sciences 113, pages 2-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.